Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HBV capsid inhibitors(HBV capsid inhibitors), HIV-1 pol inhibitors(Human immunodeficiency virus type 1 Pol protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Molecular FormulaC22H26BrFN4O6S2 |
InChIKeyFDMKMKYZDJHHFM-UHFFFAOYSA-N |
CAS Registry1646361-04-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | IND Approval | China | 06 Feb 2023 |